653 related articles for article (PubMed ID: 27374630)
1. In vivo comparative study of distinct polymeric architectures bearing a combination of paclitaxel and doxorubicin at a synergistic ratio.
Baabur-Cohen H; Vossen LI; Krüger HR; Eldar-Boock A; Yeini E; Landa-Rouben N; Tiram G; Wedepohl S; Markovsky E; Leor J; Calderón M; Satchi-Fainaro R
J Control Release; 2017 Jul; 257():118-131. PubMed ID: 27374630
[TBL] [Abstract][Full Text] [Related]
2. Anticancer polymeric nanomedicine bearing synergistic drug combination is superior to a mixture of individually-conjugated drugs.
Markovsky E; Baabur-Cohen H; Satchi-Fainaro R
J Control Release; 2014 Aug; 187():145-57. PubMed ID: 24862318
[TBL] [Abstract][Full Text] [Related]
3. A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: preparation, in vitro and in vivo evaluation.
Li Q; Lv S; Tang Z; Liu M; Zhang D; Yang Y; Chen X
Int J Pharm; 2014 Aug; 471(1-2):412-20. PubMed ID: 24905776
[TBL] [Abstract][Full Text] [Related]
4. Dendritic poly(ethylene glycol) bearing paclitaxel and alendronate for targeting bone neoplasms.
Clementi C; Miller K; Mero A; Satchi-Fainaro R; Pasut G
Mol Pharm; 2011 Aug; 8(4):1063-72. PubMed ID: 21608527
[TBL] [Abstract][Full Text] [Related]
5. Integrin-targeted nano-sized polymeric systems for paclitaxel conjugation: a comparative study.
Eldar-Boock A; Blau R; Ryppa C; Baabur-Cohen H; Many A; Vicent MJ; Kratz F; Sanchis J; Satchi-Fainaro R
J Drug Target; 2017; 25(9-10):829-844. PubMed ID: 28737432
[TBL] [Abstract][Full Text] [Related]
6. PEGylated Dendritic Polyglycerol Conjugate Delivers Doxorubicin to the Parasitophorous Vacuole in Leishmania infantum Infections.
Gutierrez-Corbo C; Dominguez-Asenjo B; Vossen LI; Pérez-Pertejo Y; Muñoz-Fenández MA; Balaña-Fouce R; Calderón M; Reguera RM
Macromol Biosci; 2017 Oct; 17(10):. PubMed ID: 28683183
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of a paclitaxel-binding polymeric micelle for efficient breast cancer therapy.
Xiang J; Wu B; Zhou Z; Hu S; Piao Y; Zhou Q; Wang G; Tang J; Liu X; Shen Y
Sci China Life Sci; 2018 Apr; 61(4):436-447. PubMed ID: 29572777
[TBL] [Abstract][Full Text] [Related]
8. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
[TBL] [Abstract][Full Text] [Related]
9. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo.
Chuan X; Song Q; Lin J; Chen X; Zhang H; Dai W; He B; Wang X; Zhang Q
Mol Pharm; 2014 Oct; 11(10):3656-70. PubMed ID: 25208098
[TBL] [Abstract][Full Text] [Related]
10. Poly(ethylene glycol)-poly(ester-carbonate) block copolymers carrying PEG-peptidyl-doxorubicin pendant side chains: synthesis and evaluation as anticancer conjugates.
Andersson L; Davies J; Duncan R; Ferruti P; Ford J; Kneller S; Mendichi R; Pasut G; Schiavon O; Summerford C; Tirk A; Veronese FM; Vincenzi V; Wu G
Biomacromolecules; 2005; 6(2):914-26. PubMed ID: 15762660
[TBL] [Abstract][Full Text] [Related]
11. Poly(ethylene glycol)-paclitaxel-alendronate self-assembled micelles for the targeted treatment of breast cancer bone metastases.
Miller K; Clementi C; Polyak D; Eldar-Boock A; Benayoun L; Barshack I; Shaked Y; Pasut G; Satchi-Fainaro R
Biomaterials; 2013 May; 34(15):3795-806. PubMed ID: 23434349
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of linear, Y-shaped and linear-dendritic methoxy poly(ethylene glycol)-block-polyamidoamine-block-poly(l-glutamic acid) block copolymers for doxorubicin delivery in vitro and in vivo.
Zhang Y; Xiao C; Ding J; Li M; Chen X; Tang Z; Zhuang X; Chen X
Acta Biomater; 2016 Aug; 40():243-253. PubMed ID: 27063495
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin receptor-mediated specific delivery of paclitaxel prodrugs for efficient cancer therapy.
Huo M; Zhu Q; Wu Q; Yin T; Wang L; Yin L; Zhou J
J Pharm Sci; 2015 Jun; 104(6):2018-2028. PubMed ID: 25820241
[TBL] [Abstract][Full Text] [Related]
14. The structure of polymer carriers controls the efficacy of the experimental combination treatment of tumors with HPMA copolymer conjugates carrying doxorubicin and docetaxel.
Šírová M; Strohalm J; Chytil P; Lidický O; Tomala J; Říhová B; Etrych T
J Control Release; 2017 Jan; 246():1-11. PubMed ID: 27940304
[TBL] [Abstract][Full Text] [Related]
15. Targeting doxorubicin to epidermal growth factor receptors by site-specific conjugation of C225 to poly(L-glutamic acid) through a polyethylene glycol spacer.
Vega J; Ke S; Fan Z; Wallace S; Charsangavej C; Li C
Pharm Res; 2003 May; 20(5):826-32. PubMed ID: 12751641
[TBL] [Abstract][Full Text] [Related]
16. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.
Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M
Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430
[TBL] [Abstract][Full Text] [Related]
17. PEG-doxorubicin conjugates: influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity.
Veronese FM; Schiavon O; Pasut G; Mendichi R; Andersson L; Tsirk A; Ford J; Wu G; Kneller S; Davies J; Duncan R
Bioconjug Chem; 2005; 16(4):775-84. PubMed ID: 16029018
[TBL] [Abstract][Full Text] [Related]
18. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
19. Integrin-assisted drug delivery of nano-scaled polymer therapeutics bearing paclitaxel.
Eldar-Boock A; Miller K; Sanchis J; Lupu R; Vicent MJ; Satchi-Fainaro R
Biomaterials; 2011 May; 32(15):3862-74. PubMed ID: 21376390
[TBL] [Abstract][Full Text] [Related]
20. The effect of size and polymer architecture of doxorubicin-poly(ethylene) glycol conjugate nanocarriers on breast duct retention, potency and toxicity.
Gu Z; Gao D; Al-Zubaydi F; Li S; Singh Y; Rivera K; Holloway J; Szekely Z; Love S; Sinko PJ
Eur J Pharm Sci; 2018 Aug; 121():118-125. PubMed ID: 29698706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
